DUBLIN, Feb. 5, 2025
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference
call and webcast presentation at 8:00 a.m.
ET (1:00 p.m. GMT) on
Wednesday, Feb. 12, 2025 to discuss
the company's fourth quarter and year-end 2024 financial results.
Management will also discuss financial expectations for 2025 and
provide an update on the company.
The webcast player and accompanying slides may be accessed on
the Investors section of Alkermes' website at www.alkermes.com. The
conference call may be accessed by dialing +1 877 407 2988 for U.S.
callers and +1 201 389 0923 for international callers. A replay of
the webcast will be available approximately two hours after the
completion of the event and may be accessed by visiting Alkermes'
website.
About Alkermes plc
Alkermes plc is a global
biopharmaceutical company that seeks to develop innovative
medicines in the field of neuroscience. The company has a portfolio
of proprietary commercial products for the treatment of alcohol
dependence, opioid dependence, schizophrenia and bipolar I
disorder, and a pipeline of clinical and preclinical candidates in
development for neurological disorders, including narcolepsy and
idiopathic hypersomnia. Headquartered in Ireland, Alkermes also has a corporate office
and research and development center in Massachusetts and a manufacturing facility in
Ohio. For more information, please
visit Alkermes' website at www.alkermes.com.
Alkermes Contact:
Jamie Constantine
Investor Relations
+1 781 873 2402
Logo -
https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-12-2025-302369002.html
